Sept 30 (Reuters) – The U.S. Food and Drug Administration has approved Novartis' oral treatment for patients with type of chronic inflammatory skin disease, the company said on Tuesday. (Reporting by Siddhi Mahatole in Bengaluru; Editing by Sahal Muhammed)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By David Shepardson WASHINGTON, Aug 20 (Reuters) - A U.S. judge rejected a request by…
By David Shepardson WASHINGTON, Aug 20 (Reuters) - A U.S. judge rejected a request by…
LONDON, Aug 20 (Reuters) - Cinema operators in Britain are introducing policies to prohibit or…
Munich (dpa) - Cocktails may look impressive but if you make these syrups yourself you…
Aug 20 (Reuters) - Prime Video said on Thursday it plans to invest more than…
LONDON, Aug 20 (Reuters) - Cinema operators in Britain are introducing policies to prohibit or…